These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2436411)

  • 1. Immunocompetent cells of fixed drug eruption.
    Visa K; Käyhkö K; Stubb S; Reitamo S
    Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of lymphocytes and Langerhans' cells in long-lasting allergic patch tests.
    Kanerva L; Estlander T; Jolanki R
    Acta Derm Venereol; 1988; 68(2):116-22. PubMed ID: 2453989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
    Thivolet J; Schmitt D; Souteyrand P; Brochier J
    Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
    Teraki Y; Shiohara T
    Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.
    Shiohara T; Mizukawa Y
    Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans' cells and interdigitating cells.
    Bos JD; Krieg SR
    Acta Derm Venereol; 1985; 65(5):390-7. PubMed ID: 2416161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption.
    Teraki Y; Moriya N; Shiohara T
    Am J Pathol; 1994 Sep; 145(3):550-60. PubMed ID: 7915886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parapsoriasis en plaques. Characterization of the cellular infiltrate using monoclonal antibodies].
    Büchner SA
    Z Hautkr; 1988 May; 63(5):423-4, 427-9. PubMed ID: 3043952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies.
    Kaudewitz P; Burg G; Majiewski G; Gerdes J; Schwarting R; Braun-Falco O
    Acta Derm Venereol; 1987; 67(1):24-9. PubMed ID: 2436410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
    Jaber SH; Cowen EW; Haworth LR; Booher SL; Berman DM; Rosenberg SA; Hwang ST
    Arch Dermatol; 2006 Feb; 142(2):166-72. PubMed ID: 16490844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.
    Bhan AK; Mihm MC; Dvorak HF
    J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ characterization of cells in the dermal infiltrates of lepromin reaction using monoclonal antibodies.
    Narayanan RB; Ramu G; Malaviya GN; Sengupta U; Desikan KV
    Indian J Lepr; 1985; 57(2):265-72. PubMed ID: 3908574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkeratosis lenticularis perstans (Flegel's disease). In situ characterization of T cell subsets and Langerhans' cells.
    Büchner SA
    Acta Derm Venereol; 1988; 68(4):341-5. PubMed ID: 2459881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular kinetics of delayed hypersensitivity test reactions to topical glucocorticosteroids.
    Lauerma AI; Visa K; Pekonen M; Förström L; Reitamo S
    Arch Dermatol Res; 1987; 279(6):379-84. PubMed ID: 3499871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.